Angerer Jürgen, Ewers Ulrich, Wilhelm Michael
Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, University of Erlangen-Nuremberg, Schillerstrasse 25/29, 91054 Erlangen, Germany.
Int J Hyg Environ Health. 2007 May;210(3-4):201-28. doi: 10.1016/j.ijheh.2007.01.024. Epub 2007 Mar 21.
Human biomonitoring (HBM) of dose and biochemical effect nowadays has tremendous utility providing an efficient and cost effective means of measuring human exposure to chemical substances. HBM considers all routes of uptake and all sources which are relevant making it an ideal instrument for risk assessment and risk management. HBM can identify new chemical exposures, trends and changes in exposure, establish distribution of exposure among the general population, identify vulnerable groups and populations with higher exposures and identify environmental risks at specific contaminated sites with relatively low expenditure. The sensitivity of HBM methods moreover enables the elucidation of human metabolism and toxic mechanisms of the pollutants. So, HBM is a tool for scientists as well as for policy makers. Blood and urine are by far the most approved matrices. HBM can be done for most chemical substances which are in the focus of the worldwide discussion of environmental medicine. This especially applies for metals, PAH, phthalates, dioxins, pesticides, as well as for aromatic amines, perfluorinated chemicals, environmental tobacco smoke and volatile organic compounds. Protein adducts, especially Hb-adducts, as surrogates of DNA adducts measuring exposure as well as biochemical effect very specifically and sensitively are a still better means to estimate cancer risk than measuring genotoxic substances and their metabolites in human body fluids. Using very sophisticated but nevertheless routinely applicable analytical procedures Hb-adducts of alkylating agents, aromatic amines and nitro aromatic compounds are determined routinely today. To extend the spectrum of biochemical effect monitoring further methods should be elaborated which put up with cleavage and separation of the adducted protein molecules as a measure of sample preparation. This way all sites of adduction as well as further proteins, like serum albumin could be used for HBM. DNA-adducts indicate the mutagenicity of a chemical substance as well as an elevated cancer risk. DNA-adducts therefore would be ideal parameters for HBM. Though there are very sensitive techniques for DNA adduct monitoring like P32-postlabelling and immunological methods they lack specificity. For elucidating the mechanism of carcinogenesis and for a broad applicability and comparability in epidemiological studies analytical methods must be elaborated which are strictly specific for the chemical structure of the DNA-adduct. Current analytical possibilities however meet their borders. In HBM studies with exposure to genotoxic chemicals especially the measurement of DNA strand breaks in lymphocytes and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in white blood cells has become very popular. However, there is still a lack of well-established dose-response relations between occupational or environmental exposures and the induction of 8-OHdG or formation of strand breaks which limits the applicability of these markers. Most of the biomarkers used in population studies are covered by standard operating procedures (SOPs) as well as by internal and external quality assessment schemes. Therefore, HBM results from the leading laboratories worldwide are analytically reliable and comparable. Newly upcoming substances of environmental relevance like perfluorinated compounds can rapidly be assessed in body fluids because there are very powerful laboratories which are able to elaborate the analytical prerequisites in due time. On the other hand, it is getting more and more difficult for the laboratories to keep up with a progress in instrumental analyses. In spite of this it will pay to reach the ultimate summit of HBM because it is the only way to identify and quantify human exposure and risk, elucidate the mechanism of toxic effects and to ultimately decide if measures have to be taken to reduce exposure. Risk assessment and risk management without HBM lead to wrong risk estimates and cause inadequate measures. In some countries like in USA and in Germany, thousands of inhabitants are regularly investigated with respect to their internal exposure to a broad range of environmentally occurring substances. For the evaluation of HBM results the German HBM Commission elaborates reference- and HBM-values.
如今,人体剂量与生化效应的生物监测(HBM)具有巨大的实用价值,它提供了一种高效且经济有效的手段来测量人体对化学物质的暴露情况。HBM考虑了所有相关的摄入途径和来源,使其成为风险评估和风险管理的理想工具。HBM能够识别新的化学暴露、暴露趋势和变化,确定一般人群中的暴露分布,识别弱势群体和高暴露人群,并以相对较低的成本识别特定污染场地的环境风险。此外,HBM方法的灵敏度能够阐明污染物的人体代谢和毒性机制。因此,HBM对于科学家和政策制定者而言都是一种工具。血液和尿液是目前最被认可的样本基质。对于全球环境医学讨论焦点中的大多数化学物质都可以进行HBM。这尤其适用于金属、多环芳烃、邻苯二甲酸盐、二噁英、农药,以及芳香胺、全氟化学品、环境烟草烟雾和挥发性有机化合物。蛋白质加合物,尤其是血红蛋白加合物,作为DNA加合物的替代物,能够非常特异且灵敏地测量暴露以及生化效应,是一种比测量人体体液中的遗传毒性物质及其代谢物更好的评估癌症风险的手段。如今,使用非常精密但仍可常规应用的分析程序,能够常规测定烷基化剂、芳香胺和硝基芳香化合物的血红蛋白加合物。为了进一步扩展生化效应监测的范围,应该研发出能够处理加合蛋白质分子的裂解和分离作为样品制备手段的方法。通过这种方式,所有加合位点以及其他蛋白质,如血清白蛋白,都可用于HBM。DNA加合物表明化学物质的致突变性以及癌症风险的升高。因此,DNA加合物将是HBM的理想参数。尽管有像32P后标记和免疫方法等非常灵敏的DNA加合物监测技术,但它们缺乏特异性。为了阐明致癌机制以及在流行病学研究中实现广泛的适用性和可比性,必须研发出对DNA加合物化学结构具有严格特异性的分析方法。然而,目前的分析方法已达到其极限。在接触遗传毒性化学物质的HBM研究中,尤其是淋巴细胞中DNA链断裂和白细胞中8 - 羟基 - 2'-脱氧鸟苷(8 - OHdG)的测量变得非常普遍。然而,职业或环境暴露与8 - OHdG诱导或链断裂形成之间仍缺乏完善的剂量 - 反应关系,这限制了这些标志物的适用性。人群研究中使用的大多数生物标志物都有标准操作程序(SOP)以及内部和外部质量评估方案。因此,全球领先实验室的HBM结果在分析上是可靠且可比的。新出现的具有环境相关性的物质,如全氟化合物,能够在体液中快速得到评估,因为有非常强大的实验室能够及时研发出分析所需条件。另一方面,实验室要跟上仪器分析的进展变得越来越困难。尽管如此,实现HBM的最终目标仍将是值得的,因为这是识别和量化人体暴露与风险、阐明毒性作用机制以及最终决定是否必须采取措施减少暴露的唯一途径。没有HBM的风险评估和风险管理会导致错误的风险估计并引发不适当的措施。在美国和德国等一些国家,数千居民会定期接受关于其体内对多种环境中存在的物质暴露情况的调查。为了评估HBM结果,德国HBM委员会制定了参考值和HBM值。